Prot #GS-US-326-1100: A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severely Active Ulcerative Colitis

Project: Research project

Project Details

StatusFinished
Effective start/end date4/15/164/15/19

Funding

  • ICON Clinical Research, LLC (Prot #GS-US-326-1100)
  • Gilead Sciences, Inc. (Prot #GS-US-326-1100)